WHO urges Bangladesh hepatitis action
Analysis based on 6 articles · First reported Jul 27, 2026 · Last updated Jul 28, 2026
The announcement may increase focus on healthcare spending in Bangladesh, potentially benefiting pharmaceutical companies involved in hepatitis treatments. However, the direct market impact is limited as the event is a public health call rather than a regulatory or economic shift.
On World Hepatitis Day, the World Health Organization (WHO) identified Bangladesh among the 10 countries with the highest hepatitis C burden globally. WHO Representative Ahmed Jamsheed Mohamed called for accelerated action to expand prevention, testing, and treatment services, noting that hepatitis is preventable, treatable, and curable yet millions lack access. Bangladesh has a National Strategic Plan 2020-2030 and has strengthened vaccination and testing, but barriers like low awareness, late diagnosis, and stigma persist. WHO recommended integrating hepatitis services into primary healthcare and improving surveillance to achieve elimination by 2030.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard